(Q51577468)

English

A pilot study of chronic, low-dose epoetin-{beta} following percutaneous coronary intervention suggests safety, feasibility, and efficacy in patients with symptomatic ischaemic heart failure.

scientific article published in May 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/21505058

A pilot study of chronic, low-dose epoetin-{beta} following percutaneous coronary intervention suggests safety, feasibility, and efficacy in patients with symptomatic ischaemic heart failure. (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/21505058

0 references

Andreas Busjahn

7

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/21505058

Friedrich C. Luft

10

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/21505058

9

object named as

Jens Jordan

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/21505058

2

object named as

Sven Haufe

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/21505058

Heidrun Mehling

4

object named as

Heidrun Mehling

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/21505058

author name string

Martin W Bergmann

1

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/21505058

Florian von Knobelsdorff-Brenkenhoff

3

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/21505058

Ralf Wassmuth

5

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/21505058

Ines Münch

6

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/21505058

Jeanette Schulz-Menger

8

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/21505058

Rainer Dietz

11

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/21505058

publication date

1 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/21505058

European Journal of Heart Failure

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/21505058

13

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/21505058

5

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/21505058

560-568

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/21505058

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR002

21 January 2018

Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR002

21 January 2018

Stem cell mobilization by granulocyte colony-stimulating factor for myocardial recovery after acute myocardial infarction: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR002

21 January 2018

A single dose of erythropoietin in ST-elevation myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR002

21 January 2018

Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR002

21 January 2018

Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR002

21 January 2018

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR002

21 January 2018

A secondary analysis of the CHOIR trial shows that comorbid conditions differentially affect outcomes during anemia treatment

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR002

21 January 2018

Erythropoietin regulates endothelial progenitor cells

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR002

21 January 2018

Erythropoietin stimulates normal endothelial progenitor cell-mediated endothelial turnover, but attributes to neovascularization only in the presence of local ischemia.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR002

21 January 2018

Single high-dose intramyocardial administration of erythropoietin promotes early intracardiac proliferation, proves safety and restores cardiac performance after myocardial infarction in rats

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR002

21 January 2018

Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR002

21 January 2018

Prevalence of anemia and effects on mortality in patients with heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR002

21 January 2018

The potential role of erythropoietin in chronic heart failure: from the correction of anemia to improved perfusion and reduced apoptosis?

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR002

21 January 2018

Endothelial progenitor cells: characterization and role in vascular biology

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR002

21 January 2018

Pressure-induced cardiac overload induces upregulation of endothelial and myocardial progenitor cells.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR002

21 January 2018

Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR002

21 January 2018

Differential mobilization of subsets of progenitor cells from the bone marrow

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR002

21 January 2018

Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR002

21 January 2018

Identifiers

10.1093/EURJHF/HFR002

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/21505058

release_fc4skgaag5cynjq4ltkwlriyty

1 reference

https://api.fatcat.wiki/v0/release/fc4skgaag5cynjq4ltkwlriyty

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/21505058

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51577468&oldid=1843818344"